Propranolol Dosing for Anxiety-Related Tachycardia
For anxiety-related tachycardia, start propranolol immediate-release at 10-40 mg three to four times daily (total 30-160 mg/day), titrating based on symptom control and heart rate response. 1
Initial Dosing Strategy
- Begin with propranolol immediate-release 10-40 mg three to four times daily, as recommended by the American College of Cardiology for symptomatic tachyarrhythmias 1
- For patients preferring once-daily dosing, the long-acting formulation can be started at 80 mg once daily, with titration to 120-160 mg daily for maintenance 1
- Improvement in somatic symptoms (tremor, palpitations) occurs within 1-2 hours at relatively low doses (40 mg/day) 2
Dose Titration and Optimization
- Most patients with anxiety achieve adequate symptom control with 80-320 mg daily of immediate-release propranolol 3
- The target is to achieve virtual abolition of orthostatic and hyperventilatory tachycardia, indicating adequate beta-blockade 3
- Approximately 50% of patients achieve clinically significant reduction in exercise tachycardia (≥20 bpm decrease) with 160 mg per day 4
- Only one-third of patients respond adequately at doses ≤160 mg/day, while an additional 40% require 200-640 mg/day for optimal effect 5
- Plasma propranolol levels above 20 ng/ml are needed to induce significant beta-blockade, typically achieved with daily doses slightly exceeding 160 mg 4
Mandatory Pre-Treatment Screening
Before initiating propranolol, you must screen for absolute contraindications:
- Cardiogenic shock or hypotension 1
- Active asthma or obstructive airway disease 1
- Perform baseline cardiovascular examination with auscultation 1
Monitoring During Treatment
- Watch for hypotension and bradycardia, especially during dose escalation 1
- In diabetic patients, counsel that propranolol may mask hypoglycemia symptoms (tremor, tachycardia) 1
- Assess symptom response at each visit and adjust dosing accordingly 1
Critical Safety Warnings
- Never abruptly discontinue propranolol after chronic use—taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 1
- Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to severe bradycardia and heart block risk 1
- Some patients exhibit a biphasic dose-response curve, where arrhythmia frequency decreases at lower doses but paradoxically increases at higher doses above the optimal level 5
Long-Term Considerations
- With sustained treatment at higher doses (160 mg/day), improvement in psychic anxiety symptoms may emerge after several weeks, beyond the immediate somatic symptom relief 2
- Propranolol requirements often diminish over time, and lasting remissions are not infrequent 3
- Depression, present in approximately 50% of anxiety patients, usually improves with propranolol but may persist in one-third as a lone symptom requiring antidepressant therapy 3
Alternative Formulation for Acute Situations
- For acute anxiety episodes requiring rapid control, IV propranolol can be given as 1 mg over 1 minute, repeated every 2 minutes up to 3 doses maximum 1